Human Genome Sciences: challenging the pegylated interferons (Hep C Treatment)

Human Genome Sciences: challenging the pegylated interferons
Pharmaceutical Business Review - Mar 15, 2006... puts Albuferon in a strong position to potentially replace pegylated interferon, the drug's success might be delayed by the approval of specific HCV inhibitors ...

Fayette residents hear about bloodless medicine
Uniontown Herald Standard, PA - Mar 18, 2006... "Most blood transfusion patients fear diseases such as HIV, HCV, Hepatitis B and others,'' Doebler said. This program takes away those chances.''. ...

Coley begins trial of Actilon in hepatitis
Pharmaceutical Business Review - Feb 27, 2006... The phase II clinical trial is expected to enroll 90 adults with genotype 1 hepatitis C virus (HCV) who have failed previous therapy with the current standard ...